10 Alzheimers Disease Clinical Trials in Huntersville, NC (2026)

Q: How do I join a clinical trial in Huntersville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntersville research site will contact you.

Recruiting Alzheimers Disease Studies in Huntersville

NCT00571389Recruiting

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Primary Objective: This is a study to investigate the feasibility of harvesting, expanding, and selecting T lymphocytes from cancer patients and healthy volunteers. The preliminary objective of this ...

Huntersville, NC1,500 participantsBioCytics, Inc.

View Study Details

NCT06545331Recruiting

Study of XB010 in Subjects With Solid Tumors

This is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with lo...

Huntersville, NCPHASE1396 participantsExelixis

View Study Details

NCT04977453Recruiting

GI-101 as a Single Agent or in Combination With Pembrolizumab, Lenvatinib or Local Radiotherapy in Advanced Solid Tumors

The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-101/GI-101A as a single agent or in combination with pembrolizumab, lenvatinib or lo...

Huntersville, NCPHASE1317 participantsGI Innovation, Inc.

View Study Details

NCT07109726Recruiting

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

This is a Phase 1/2, open-label, multicenter study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics and anti-tumor activity of TER-2013 in patients with advanced solid tumors ha...

Huntersville, NCPHASE1205 participantsTerremoto Biosciences Inc.

View Study Details

NCT07360314Recruiting

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

The purpose of this first-in-human (FIH) study is to evaluate the safety, tolerability, Pharmacokinetics (PK), and preliminary clinical activity of M7437 in participants with locally advanced or metas...

Huntersville, NCPHASE1138 participantsEMD Serono Research & Development Institute, Inc.

View Study Details

NCT06399757Recruiting

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

This is an open-label, Phase 1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors with particular focus o...

Huntersville, NCPHASE1100 participantsApollo Therapeutics Ltd

View Study Details

NCT05892718Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

The purpose of this study is to find out whether IV injection of HCB101 is an effective treatment for different types of advanced solid tumors or relapsed and refractory non-Hodgkin lymphoma and what ...

Huntersville, NCPHASE180 participantsFBD Biologics Limited

View Study Details

NCT05329103Recruiting

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

This is a first-in-human, dose escalation, repeat-dose, multi-center, open-label study evaluating safety, tolerability, PK, and preliminary antitumor activity of PEEL-224 in patients with advanced sol...

Huntersville, NCPHASE165 participantsPeel Therapeutics Inc

View Study Details

NCT07161414Recruiting

A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants With Advanced Solid Tumors Previously Treated With Standard of Care Therapy

The purpose of this study is to determine the subcutaneous (SC) dose that gives rilvegostomig exposure comparable to the intravenous (IV) exposure, and to evaluate the pharmacokinetics (PK) and safety...

Huntersville, NCPHASE140 participantsAstraZeneca

View Study Details

NCT06750185Recruiting

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

This is a first-in-human (FIH), open-label, multiple-site, dose escalation study which will evaluate the safety, tolerability, pharmacokinetics (PK), and immunogenicity of increasing doses of BNT317 i...

Huntersville, NCPHASE139 participantsBioNTech SE

View Study Details

About Alzheimers Disease Clinical Trials in Huntersville

Alzheimer's disease is a progressive brain disorder that destroys memory, thinking skills, and the ability to carry out daily tasks. It is the most common cause of dementia, affecting over 6.7 million Americans age 65 and older. The disease is characterized by amyloid-beta plaques and tau tangles in the brain. Recent FDA approvals of anti-amyloid antibodies like lecanemab (Leqembi) and donanemab have opened a new era of disease-modifying treatments. Clinical trials are now exploring next-generation amyloid-clearing therapies, tau-targeting treatments, anti-inflammatory approaches, and combination strategies. Early-stage patients with mild cognitive impairment or early Alzheimer's are frequently sought for enrollment, and many trials now use blood-based biomarkers for screening.

There are currently 10 alzheimers disease clinical trials recruiting participants in Huntersville, NC. These studies are seeking a combined 2,880 participants. Research is being sponsored by BioCytics, Inc., Exelixis, GI Innovation, Inc. and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Alzheimers Disease Clinical Trials in Huntersville — FAQ

Are there alzheimers disease clinical trials in Huntersville?

Yes, there are 10 alzheimers disease clinical trials currently recruiting in Huntersville, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Huntersville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntersville research site will contact you about next steps.

Are clinical trials in Huntersville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntersville studies also compensate for your time and travel.

What alzheimers disease treatments are being tested?

The 10 active trials in Huntersville are testing new therapies including novel drugs, biologics, and treatment approaches for alzheimers disease.

Data updated July 22, 2026 from ClinicalTrials.gov